TAIPEI -- CYTENA Bioprocess Solutions, a BICO company, has launched the S.NEST™, a state-of-the art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed their new microbioreactor to disrupt the field of cell line development (CLD). [...]

SpeeDx have further expanded their product line of research reagents for COVID-19 variant analysis to include a key characteristic mutation connected to the SARS-CoV-2 Lambda variant of interest (VOI). The PlexPrime® SARS-CoV-2 Genotyping product line has rapidly expanded since launching in July, utilising the company’s unique universal substrate approach and patented multiplexing technology. “The individual mutations targeted [...]

MAHWAH, N.J. -- Globe Scientific, a producer of reliable laboratory plastics, glass and equipment for scientific, education, clinical and specialty markets introduces Diamond® PureFlow™ Syringe Filters to their product line.  The syringe filters provide a high-quality, cost-effective filtration system that improves the reliability of experimental results and decreases instrument downtime for laboratory professionals. Diamond PureFlow syringe [...]

Existing CHO platform, featuring low cost and no royalty or license tie-ins, expands with new cell line to help develop biotherapeutics with increased potency and longevity and decreased side effects WALTHAM, Mass. -- PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced that its Horizon Discovery CHOSOURCE™ platform is expanding [...]

Dr. Kelly brings 15 years of executive-level experience to RoosterBio after having led several highly specialized life sciences manufacturing companies FREDERICK, Md. -- RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) bioprocess systems for cell and gene therapy product developers, today announced Timothy M. Kelly, PhD, has joined the company as Chief Executive Officer [...]

CARLSBAD, Calif. -- Since the emergence of SARS-CoV-2, public health laboratories and researchers have been developing surveillance methods using wastewater to control the spread of COVID-19. The effort has helped identify asymptomatic carriers on college campuses to monitor regional spread among communities and capture emerging mutations ahead of potential future outbreaks. To support these efforts, [...]

New Oncology Service supports unique in vitro investigations into the PK/PD relationship Harnesses CN Bio’s proprietary PhysioMimix™ PK system Represents first implementation of intellectual property licensed from Vanderbilt University to provide human-relevant insights into combination therapies and dosing schedules previously only obtained in vivo Cambridge, UK: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and [...]

Merck today announced that its Life Science business sector has signed an agreement licensing its patented CRISPR-Cas9 technology to Cellecta, Inc., a functional genomics products and services provider ... Merck’s fundamental genome-editing tool helps identify innovative treatments in cellular and genetic diseases Company’s licensing enables researchers and scientists to advance treatments for inherited blood disorders, [...]

Appointments will drive commercialization and development of proprietary next-generation sequencing library prep technologies Beverly MA, US, 05 October 2021: seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing platform, today announced five appointments to its commercial team. Led by Steve Smith, who joins as Chief Commercial Officer, the team will be [...]

NORDERSTEDT, Germany, October 05, 2021 / B3C newswire / -- Cellbox Solutions GmbH has recruited Dr. Gisèle Deblandre to the team. The well-known industry expert joins the biotechnology company as Chief Scientific Officer (CSO) effective today. With her extensive knowledge in the development of manufacturing processes and analytical methods for cell-based therapies and ex-vivo gene therapies, Deblandre will be [...]